Zimmermann M, Jung C S, Vatter H, Raabe A, Seifert V
Department of Neurosurgery, Johann Wolfgang Goethe - University Frankfurt/Main, Germany.
Acta Neurochir (Wien). 2002 Nov;144(11):1213-9. doi: 10.1007/s00701-002-1000-z.
The aim of this study was to investigate whether blocking functional endothelin-converting enzyme (ECE) activity may offer a new approach to inhibit the development of cerebral vasopasm after subarachnoid hemorrhage (SAH) by preventing transformation of big Endothelin-1 (big ET-1) to vasoactive Endothelin-1 (ET-1).
In vitro, the effect of potential ECE inhibitors was determined by measurement of isometric contractions, induced by big ET-1, in isolated rat basilar arteries. Endothelium intact (E+) and de-endothelialized (E-) segments were examined after pre-incubated with the putative ECE inhibitors: Phosphoramidon (10(-4) M), Captopril (10(-3) M and 10(-4) M) and [(22)D-Val] big ET-1 (16-38) (10(-5) M and 10(-6) M).
Application of 10(-4) M Phosphoramidon resulted in a statistically significant decrease in big ET-1 induced contraction in endothelium intact (E+) and de-endothelialized (E-) segments; 10(-3) M Captopril in E- segments caused a statistically significant inhibitory effect; 10(-4) M and 10(-3) M Captopril in E+ segments showed no statistically significant effect; 10(-5) M and 10(-6) M [(22)D-Val] big ET-1 (16-38) in E- segments produced no statistically significant effect. The application of 10(-6) M [(22)D-Val] big ET-1 (16-38) in E+ segments caused increased contractions as shown by the shift to the left of the concentration-effect curve (CEC).
The present study indicates the existence of functional ECE activity in rat basilar artery, which is different in the endothelium and the smooth muscle layer. This ECE-activity could be inhibited by Captopril and Phosporamidon, suggesting a potency for prevention and therapy of cerebral vasospasm. However, the structural analogue of big ET-1, [(22)D-Val] big ET-1 (16-38), was ineffective in reducing big ET-1 induced vasoconstriction and rather increased contraction in E+ vessels. Therefore further studies of the biochemical nature of the functional relevant cerebrovascular ECE activity are required for better understanding and development of other efficient ECE inhibitors.
本研究的目的是探讨阻断功能性内皮素转换酶(ECE)活性是否可以通过防止大内皮素-1(big ET-1)转化为血管活性内皮素-1(ET-1),为抑制蛛网膜下腔出血(SAH)后脑血管痉挛的发展提供一种新方法。
在体外,通过测量大ET-1诱导的离体大鼠基底动脉等长收缩,来确定潜在ECE抑制剂的作用。在用假定的ECE抑制剂:磷酰胺素(10⁻⁴ M)、卡托普利(10⁻³ M和10⁻⁴ M)以及[(22)D-缬氨酸]大ET-1(16-38)(10⁻⁵ M和10⁻⁶ M)预孵育后,检查内皮完整(E+)和去内皮(E-)节段。
应用10⁻⁴ M磷酰胺素导致内皮完整(E+)和去内皮(E-)节段中大ET-1诱导的收缩在统计学上显著降低;10⁻³ M卡托普利在E-节段产生了统计学上显著的抑制作用;10⁻⁴ M和10⁻³ M卡托普利在E+节段未显示出统计学上显著的效果;10⁻⁵ M和10⁻⁶ M [(22)D-缬氨酸]大ET-1(16-38)在E-节段未产生统计学上显著的效果。在E+节段应用10⁻⁶ M [(22)D-缬氨酸]大ET-1(16-38)导致收缩增加,浓度-效应曲线(CEC)向左移动表明了这一点。
本研究表明大鼠基底动脉中存在功能性ECE活性,其在内皮和平滑肌层有所不同。这种ECE活性可被卡托普利和磷酰胺素抑制,提示其在预防和治疗脑血管痉挛方面具有潜力。然而,大ET-1的结构类似物[(22)D-缬氨酸]大ET-1(16-38)在减少大ET-1诱导的血管收缩方面无效,反而增加了E+血管中的收缩。因此,需要进一步研究与功能相关的脑血管ECE活性的生化性质,以更好地理解并开发其他有效的ECE抑制剂。